US Broker Ratings

Amgen Inc. (AMGN) Stock Analysis: A 13.4% Potential Upside with Robust Dividend Yield

For individual investors seeking both growth and income, Amgen Inc. (NASDAQ: AMGN) presents a compelling picture. Positioned within the healthcare sector, Amgen is a leader in drug manufacturing with a..

Boston Scientific Corporation (BSX) Stock Analysis: A Strong Buy with 10.34% Potential Upside

Boston Scientific Corporation (NYSE: BSX), a heavyweight in the healthcare sector with a market cap of $157.61 billion, continues to capture the attention of investors with its robust market presence..

Veeva Systems Inc. (VEEV) Stock Analysis: Exploring a 2.91% Upside with Robust Revenue Growth

For investors seeking exposure in the healthcare technology space, Veeva Systems Inc. (NYSE: VEEV) presents an intriguing opportunity. With a market capitalization of $46.31 billion and a strong presence in..

BeOne Medicines Ltd. (ONC) Stock Analysis: A Promising 37% Upside Potential in the Biotech Sector

BeOne Medicines Ltd. (ONC), a Switzerland-based biotechnology company, is making significant strides in the healthcare sector, particularly in oncology. With a market capitalization of $28.04 billion and a diverse portfolio..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Exploring a 20% Upside Potential in the Healthcare Sector

IQVIA Holdings, Inc. (NYSE: IQV), a formidable player in the healthcare sector, particularly in diagnostics and research, is presenting an intriguing opportunity for investors. With a market capitalization of $27.24..

Hologic, Inc. (HOLX) Stock Analysis: Assessing a Healthcare Pioneer with 3.48% Potential Upside

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector with a solid foothold in medical instruments and supplies, is gaining investor attention as analysts forecast a potential upside..

BioMarin Pharmaceutical (BMRN) Stock Analysis: Unveiling a 73.65% Potential Upside

For investors seeking promising opportunities within the biotechnology sector, BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) presents an intriguing case. With a market capitalization of $10.58 billion, BioMarin stands as a key..

The Cooper Companies, Inc. (COO) Stock Analysis: Exploring a 30.76% Potential Upside

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, is capturing attention with its notable potential upside of 30.76%. With a market capitalization of $14.19 billion,..

AptarGroup, Inc. (ATR) Stock Analysis: A Closer Look at Its 12.31% Potential Upside

In the competitive sector of healthcare, AptarGroup, Inc. (NYSE: ATR) stands out as a key player in the medical instruments and supplies industry. With a market capitalization of $10.29 billion,..

Novo Nordisk A/S (NVO) Stock Analysis: Strong Growth and Impressive 35% Upside Potential

Novo Nordisk A/S (NYSE: NVO), a titan in the healthcare sector with a market capitalization of $304.6 billion, has been catching the eyes of investors, particularly given its substantial potential..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating Growth with a 75% Revenue Surge Amidst Market Volatility

Tempus AI, Inc. (NASDAQ: TEM) is making waves in the healthcare technology sector, attracting significant attention with its impressive revenue growth of 75.40%. This Chicago-based company, specializing in advanced healthcare..

West Pharmaceutical Services, Inc. (WST) Stock Analysis: Uncovering a 27.40% Potential Upside

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $15.72 billion,..

Exact Sciences Corporation (EXAS) Stock Analysis: Strong Buy Ratings and a Promising 27.6% Upside Potential

Exact Sciences Corporation (NASDAQ: EXAS), a key player in the healthcare sector specializing in diagnostics and research, presents a compelling opportunity for investors seeking exposure to innovative cancer screening and..

Merck & Company, Inc. (MRK) Stock Analysis: Exploring a 28.68% Potential Upside for Investors

For individual investors seeking opportunities in the healthcare sector, Merck & Company, Inc. (NYSE: MRK) presents a compelling case with a potential upside of 28.68%. With a market capitalization of..

Zoetis Inc. (ZTS) Stock Analysis: Strong Buy Ratings and 24.89% Potential Upside Drive Investor Interest

Zoetis Inc. (NYSE: ZTS), a leader in the healthcare sector, continues to capture investor attention with its robust market presence and potential for significant upside. With a market capitalization of..

ResMed Inc. (RMD) Stock Analysis: Navigating Growth in Healthcare with a 25.81% ROE

ResMed Inc. (RMD), a titan in the healthcare sector, is making waves in the medical instruments and supplies industry. With a solid market capitalization of $37.41 billion, ResMed stands as..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a 27.49% Potential Upside in the Medical Instruments Sector

Investors are turning their gaze towards Becton, Dickinson and Company (NYSE: BDX), a heavyweight in the healthcare sector specializing in medical instruments and supplies. With a market capitalization of $48.97..

Johnson & Johnson (JNJ) Stock Analysis: Exploring a Potential 11% Upside in the Healthcare Giant

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, commands a significant presence in the pharmaceutical and medical technology industries. With a market capitalization of $366.71 billion, this..

Smith & Nephew SNATS, Inc. (SNN) Investor Outlook: A 9.7% Upside Potential Amidst Steady Growth

Smith & Nephew SNATS, Inc. (NYSE: SNN), a stalwart in the healthcare sector, stands out in the medical devices industry with its robust market presence and innovative product offerings. With..

Incyte Corporation (INCY): Investor Outlook on Promising Biotech Growth with 9.91% Potential Upside

Incyte Corporation (NASDAQ: INCY) stands as a compelling player in the biotechnology sector, with its focus on the discovery, development, and commercialization of groundbreaking therapeutics. Headquartered in Wilmington, Delaware, the..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds